Pinnacle Wealth Planning Services’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Other funds holding OCUL
Pinnacle Wealth Planning Services's OCUL Position: Q3 2026 in Review
Pinnacle Wealth Planning Services reduced its Ocular Therapeutix (OCUL) stake by 33% in Q3 2026, selling an estimated $5K and leaving 1,040 shares worth $7.98K. The position accounts for ﹤0.01% of the portfolio, ranked #2171.
Pinnacle Wealth Planning Services first reported a position in OCUL in Q1 2026 and has held it in 3 quarters since. The position peaked at $15.2K in Q2 2026. 42 funds tracked by Wall St. Rank hold OCUL as of Q3 2026.
- Pinnacle Wealth Planning Services held 1,040 shares of Ocular Therapeutix worth $7.98K as of Q3 2026.
- Pinnacle Wealth Planning Services sold 511 Ocular Therapeutix shares in Q3 2026, an estimated $5K.
- Ocular Therapeutix made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2171 holding.
- Pinnacle Wealth Planning Services first reported a position in Ocular Therapeutix in Q1 2026 and has held it in 3 quarters since.
- Pinnacle Wealth Planning Services's Ocular Therapeutix position peaked at $15.2K in Q2 2026.
- 42 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q3 2026.
Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.